Related Experiment Video
Updated: Aug 9, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
A Noncanonical MET Exon 14 Splice-Site Variant in Pulmonary Sarcomatoid Carcinoma With Response to Capmatinib
Hyung-Joo Oh1,2, Yoo-Duk Choi2,3, Yoon-La Choi4
1Division of Pulmonology, Department of Internal Medicine, Chonnam National University Medical School, Gwangju, South Korea.
Abstract:
MET exon 14 skipping is an actionable oncogenic driver in non-small cell lung carcinoma (NSCLC); however, noncanonical splice-region variants are frequently classified as variants of unknown significance (VUS), which may result in missed therapeutic opportunities and highlight limitations in current DNA next-generation sequencing (NGS) reporting criteria. We report a patient with pulmonary sarcomatoid carcinoma harboring a noncanonical MET splice donor-proximal indel (c.3022_3028 + 13delinsA), initially interpreted as a VUS, who achieved a rapid and durable response to capmatinib. Subsequent RNA sequencing and droplet digital PCR (ddPCR) confirmed MET exon 14 skipping, supporting the value of orthogonal transcript-level validation for exon-adjacent variants.
Insights
MET exon 14 skipping in non-small cell lung cancer (NSCLC) can be targeted with therapies. Noncanonical variants initially classified as VUS were confirmed to drive MET exon 14 skipping, enabling successful capmatinib treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MET exon 14 skipping is a key driver in non-small cell lung carcinoma (NSCLC).
- Noncanonical splice-region variants are often misclassified as variants of unknown significance (VUS).
- This misclassification can lead to missed treatment opportunities for NSCLC patients.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
